Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

NCT01122888 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Adult Solid Neoplasm
Recurrent Adult Brain Neoplasm

Interventions

DRUG: Cilengitide
OTHER: Clinical Observation
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)